; it is currently the most commonly mutated gene found in hulman cancer (Hollstein et al., 1991) . Levels of p53 protein in normal cells are usually low owing to a short half-life. However, the protein becomes stabilised, and as a consequence detectable, after exposure to DNA-damaging agents such as UV light (Maltzman and Czyzyk, 1992; Lu and Lane, 1993) and radiation (Kastan et al., 1992; Kuerbitz et al., 1992) . The elevated levels of p53 are associated with an increase in the transcription of p53-responsive genes, resulting in the induction of growth arrest and apoptosis (Lane, 1994) . The (Saunders et al., 1991) and in whom both proliferation and DNA aneuploidy had been assessed using bromodeoxyuridmne incorporation and flow cytometry (Wilson et al., 1991; Bennett et al., 1992 (Figure 1 ). This fell into three basic categories; either the whole tumour specimen was essentially positive for p53 (>80%) (Figure la) or negative (<5%) (Figure lb) , or there were specimens in which staining was sporadic (between 5% and 80%). The latter pattern was sometimes related to differentiation (Figure Ic) in that expression decreased as cells progressed towards maturation, or it could be truly sporadic showing a random distribution of positivity throughout the specimen ( Figure Id) . The other striking feature of the staining was the variation in intensity. As might be expected, there was a strong correlation between p53 staining intensity and staining pattem (Figure 2 ) in that more intense staining was associated with tumours in which all cells were positive for p53 and the inverse was true for tumours which showed sporadic positivity.
p53 and DNA index Figure 3 shows the incidence of aneuploidy as a function of p53 staining pattern and intensity. The overall incidence of aneuploidy was 49% in this group of tumours. The presence or absence of p53 showed no relationship with gross DNA abnormalities.
However, intensity of staining did show a relationship with DNA index in that a significantly higher incidence of aneuploidy (P<0.048) was found in tumours expressing high amounts of p53 compared with those with weak expression. Neither pattern of staining nor intensity showed any correlation with absolute DNA index values. (Figure 4a ). Proliferation pattern, which we consider to be a biological indicator of tissue organisation in squamous cell carcinoma, did show a trend towards the more disorganised tumours (mixed and random) to be more commonly associated with complete p53 positivity. Similarly, the same relationship was found with intensity of staining, i.e. strong staining was more commonly associated with more disorganised tumours (Figure 4b ). However, neither of these results was significant. p53 and local tumour control Freedom from local recurrence represents a better indication of radiation response than overall survival owing to other confounding factors contributing to the latter; a significant number of head and neck cancer patients may die of intercurrent heart disease. However, neither p53 pattern of staining (either individually or comparing all positive versus negative tumours) (Figure 5a ) nor p53 staining intensity ( Figure 5b) a §i\\\\.
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Our study agrees with others that p53 overexpression is a frequent event in head and neck cancer. The overall detection rate was 76% in this series from various sites within the head and neck region, which is in agreement with a series of papers recently reviewed on head and neck squamous cell cancer (Field et al., 1993) . These studies, like our own, demonstrate a lack of correlation between p53 expression and cinicopathological parameters.
Tumours clearly manifest different patterns of p53 expres- Lack of correlation between p53 overexpression and DNA aneuploidy and proliferation was reported by Frank et al. (1994) in hypopharyngeal tumours. In that study, proliferation was assessed as S-phase fraction from DNA profile analysis. The technique we have used in this study gives a more comprehensive measure of proliferation, but it has also failed to show any association with p53 expression.
The participation of p53 protein in the cellular response to DNA damage might suggest that alterations in protein expression would influence sensitivity to ionising radiation. However, recent studies in cell lines have suggested that this is not the case. Brachman et al. (1993) showed that p53 mutation did not correlate with radiosensitivity, assessed by SF2 measurements, in a panel of 24 head and neck cancer cells which were isogeneic, except for p53 functional status, was not associated with increased sensitivity to ionising radiation (Slichemnyer et al., 1993) . This information, coupled with earlier observations that caffeine-enhanced radlotoxicity is primanrly a G, event and that delaying cell cycle progression in AT cells does not enhance radiation sensitivity, suggests that the GI checkpoint plays a minor role in determining radiation sensitivity (Murnane and Schwartz, 1993) . In this study, outcome of accelerated radiotherapy was independent of the presence of p53 protein. If any schedule might be expected to uncover a role for p53 in radiation sensitivity it should be an accelerated schedule such as CHART, which overcomes other confounding factors such as proliferation.
The initial promise of p53 as a marker of disease progression and an indicator of DNA damage response is not yet fulfilled in head and neck cancer, although this may not be true of other cancers such as breast and colon. This is in keeping with new knowledge of the function of this tumoursuppressor gene. Compelling evidence now suggests that switch-on of apoptosis may be the main function of altered p53 levels in some cell types, e.g. haematopoietic, thymocytes, whilst in others. e.g. fibroblasts. a cell cycle delay is induced. The picture is also complicated by the finding that stabilisation of p53 protein is not necessarily a result of mutation-altered conformational changes (Lane, 1994) . Protein stabilisation occurs in vivo after exposure to mild sunburn (Hall et al., 1993) . It is likely that stabilisation might involve the action of other gene products, and accumulation of p53 to high levels in tumour cells may be more related to the tumour environment, and that the tumour cell may be in a permanent state of damage related to chromosomal breakages (Lane. 1994) .
Future investigations for p53 in head and neck cancer should establish its role in initiation and progression of the disease, its interaction with mutagens, such as found in tobacco, and viral proteins. Although this study showed no correlation with outcome of accelerated radiotherapy, it would be prudent to study p53 abnormalities with other treatment regimens and with full knowledge of both protein and gene status.
